A detailed history of Nebula Research & Development LLC transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 75,417 shares of IDYA stock, worth $1.58 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
75,417
Previous 70,763 6.58%
Holding current value
$1.58 Million
Previous $2.24 Billion 13.54%
% of portfolio
0.23%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$24.79 - $31.98 $115,372 - $148,834
4,654 Added 6.58%
75,417 $1.94 Billion
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $1.17 Million - $1.65 Million
38,393 Added 118.61%
70,763 $2.24 Billion
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $436,705 - $552,202
12,706 Added 64.62%
32,370 $1.14 Billion
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $672,508 - $926,764
19,664 New
19,664 $863 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.01B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.